Therapy News and Research

RSS

Study finds no increase in muscle-related symptoms when patients are unaware of taking statin therapy

When patients were unaware they were taking statins there was no reported increase in muscle-related symptoms. But, when patients knew they were taking a statin, they were more likely to report symptoms, a finding consistent with the nocebo effect.

4 May 2017

Novel way of delivering oxygen therapy may help patients with exacerbation of COPD

A new study finds that delivery of oxygen via high-flow nasal tubes may help patients who experience exacerbations of chronic obstructive pulmonary disease.

4 May 2017

‘Helistroke service’ gets critical care to stroke victims faster than transporting patient to hospital

Flying a stroke specialist by helicopter to a nearby stroke patient for emergency care is feasible, saves money and, most importantly, gets critical care to patients faster than transporting the patient to a hospital first, according to a single-patient, proof-of-concept study by a Johns Hopkins Medicine research team.

3 May 2017

More than half of NHS patients display symptoms of relapse after depression treatments, study finds

A new study has shown that approximately 53 per cent of NHS patients displayed clinical symptoms of depression and anxiety within a year after completing psychological treatments.

3 May 2017

Social smokers' risk for high blood pressure and cholesterol is identical to regular users, study finds

Social smokers' risk for high blood pressure and high cholesterol is identical to those who light up every day, new research has found.

3 May 2017

EKF Diagnostics expands the distribution of its Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC regions

EKF, announces that it is expanding the distribution of its Procalcitonin LiquiColor Test into Eastern Europe, Middle East and APAC regions.

From EKF Diagnostics 3 May 2017

Scientists map genetic changes that help drive aggressive brain tumor

University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators have mapped genetic changes that help drive an aggressive tumor as it develops in the brain – helping to lay the foundation for targeted treatment of the disease.

3 May 2017

Findings highlight need to improve quality of care for high-risk patients with peripheral artery disease

Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.

3 May 2017

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

A newly released study published in the Journal of Immunity, Inflammation and Disease and conducted by the Sapienza University of Rome, Italy, found a multi-strain, high concentration, probiotic formulation that helped reconstitute the physical and immunological integrity of the gastrointestinal lining in HIV-1-positive patients on antiretroviral therapy.

3 May 2017

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.

3 May 2017

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

3 May 2017

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, “The State of Biosimilars Policy.” The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.

3 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

Discovery of protein that causes liver disease brings hope for new treatments

In a world-first discovery, scientists at Sydney’s Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.

3 May 2017

Molecular drug imaging likely to benefit children with brain tumors

Brain cancers are difficult to treat, and it can be hard to predict whether a therapy will be effective. When the patient is a child, it's even more important to predict the potential effectiveness of a drug before beginning treatment.

3 May 2017

Survey shows nearly 90% of patients on warfarin would like to self-monitor

Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for people on warfarin anticoagulant therapy.

3 May 2017

NIST chemists publish new data on important compound’s thermodynamic properties

Amantadine hydrochloride may be the most common medication you've never heard of. This compound has been around for decades as the basis for antiviral and other medications, from flu therapy to treatments for brain disorders such as Parkinson's disease and the fatigue associated with multiple sclerosis.

2 May 2017

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017

Researchers use simple blood tests to improve treatment for resistant hypertension in Africa

Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

2 May 2017

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Kidney cancer patients may soon have an alternative to traditional treatments, new research at UT Southwestern Medical Center's Kidney Cancer Program of the Harold C. Simmons Comprehensive Cancer Center shows.

2 May 2017

Therapy News and Research

Study finds no increase in muscle-related symptoms when patients are unaware of taking statin therapy

Novel way of delivering oxygen therapy may help patients with exacerbation of COPD

‘Helistroke service’ gets critical care to stroke victims faster than transporting patient to hospital

More than half of NHS patients display symptoms of relapse after depression treatments, study finds

Social smokers' risk for high blood pressure and cholesterol is identical to regular users, study finds

EKF Diagnostics expands the distribution of its Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC regions

Scientists map genetic changes that help drive aggressive brain tumor

Findings highlight need to improve quality of care for high-risk patients with peripheral artery disease

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Discovery of protein that causes liver disease brings hope for new treatments

Molecular drug imaging likely to benefit children with brain tumors

Survey shows nearly 90% of patients on warfarin would like to self-monitor

NIST chemists publish new data on important compound’s thermodynamic properties

Infantile spasms and multiple sclerosis relapse data presented at AAN

Researchers use simple blood tests to improve treatment for resistant hypertension in Africa

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News